| Year |
Title |
Altmetric |
| 2018
|
Pathology, chemoprevention, and preclinical models for target validation in Barrett esophagus.
Cancer Research.
78:3747-3754.
2018
|
|
| 2018
|
Myeloid-derived suppressor cells impair B cell responses in lung cancer through IL-7 and STAT5.
Journal of Immunology.
201:278-295.
2018
|
|
| 2017
|
Silencing of TGF-β1 in tumor cells impacts MMP-9 in tumor microenvironment.
Scientific Reports.
7.
2017
|
|
| 2017
|
Mesenchymal stem cells expressing osteoprotegerin variants inhibit osteolysis in a murine model of multiple myeloma.
Blood Advances.
1:2375-2385.
2017
|
|
| 2017
|
Effects of cellular methylation on transgene expression and site-specific integration of adeno-associated virus.
Genes.
8.
2017
|
|
| 2017
|
Endostatin inhibits androgen-independent prostate cancer growth by suppressing nuclear receptor-mediated oxidative stress.
Federation proceedings.
31:1608-1619.
2017
|
|
| 2017
|
Location of tumor affects local and distant immune cell type and number:.
Immunity, Inflammation and Disease.
5:85-94.
2017
|
|
| 2017
|
Osteoclast proton pump regulator Atp6v1c1 enhances breast cancer growth by activating the mTORC1 pathway and bone metastasis by increasing V-ATPase activity.
Oncotarget.
8:47675-47690.
2017
|
|
| 2017
|
Resveratrol induces mitochondria-mediated, caspaseindependent apoptosis in murine prostate cancer cells.
Oncotarget.
8:20895-20908.
2017
|
|
| 2016
|
Immature myeloid cells are critical for enhancing bone fracture healing through angiogenic cascade.
BONE.
93:113-124.
2016
|
|
| 2016
|
Prostate cancer-derived cathelicidin-related antimicrobial peptide facilitates macrophage differentiation and polarization of immature myeloid progenitors to protumorigenic macrophages.
Prostate.
76:624-636.
2016
|
|
| 2016
|
Indoleamine 2,3-dioxygenase regulates anti-tumor immunity in lung cancer by metabolic reprogramming of immune cells in the tumor microenvironment.
Oncotarget.
7:75407-75424.
2016
|
|
| 2015
|
SOCS3 deficiency in myeloid cells promotes tumor development: Involvement of STAT3 activation and myeloid-derived suppressor cells.
Cancer Immunology Research.
3:727-740.
2015
|
|
| 2015
|
Endostatin: A novel inhibitor of androgen receptor function in prostate cancer.
Proceedings of the National Academy of Sciences.
112:1392-1397.
2015
|
|
| 2015
|
Variants of osteoprotegerin lacking trail binding for therapeutic bone remodeling in osteolytic malignancies.
Cell Growth and Differentiation.
13:819-827.
2015
|
|
| 2014
|
Anterior gradient protein-2 is a regulator of cellular adhesion in prostate cancer.
PLoS ONE.
9.
2014
|
|
| 2014
|
Detection of Merkel cell polyomavirus in formalin-fixed, paraffin-embedded tissue of merkel cell carcinoma and correlation with prognosis.
Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.
55:1057-1062.
2014
|
|
| 2014
|
The dual targeting of immunosuppressive cells and oxidants promotes effector and memory T-cell functions against lung cancer.
OncoImmunology.
3.
2014
|
|
| 2013
|
Enhancement of antitumor immunity in lung cancer by targeting myeloid-derived suppressor cell pathways.
Cancer Research.
73:6609-6620.
2013
|
|
| 2013
|
Myeloid-derived suppressor cells as osteoclast progenitors: A novel target for controlling osteolytic bone metastasis.
Cancer Research.
73:4606-4610.
2013
|
|
| 2013
|
Myeloid-derived suppressor cells as a novel target for the control of osteolytic bone disease.
OncoImmunology.
2.
2013
|
|
| 2013
|
Muscle-directed anti-Aβ Single-Chain Antibody Delivery Via AAV1 reduces cerebral Aβ load in an Alzheimer's disease mouse model.
Journal of Molecular Neuroscience.
49:277-288.
2013
|
|
| 2013
|
Polyglutamate directed coupling of bioactive peptides for the delivery of osteoinductive signals on allograft bone.
Biomaterials.
34:1506-1513.
2013
|
|
| 2013
|
Role of plasmacytoid dendritic cells in breast cancer bone dissemination.
OncoImmunology.
2.
2013
|
|
| 2013
|
Myeloid-derived suppressor cells function as novel osteoclast progenitors enhancing bone loss in breast cancer.
Cancer Research.
73:672-682.
2013
|
|
| 2012
|
Depletion of plasmacytoid dendritic cells inhibits tumor growth and prevents bone metastasis of breast cancer cells.
Journal of Immunology.
189:4258-4265.
2012
|
|
| 2012
|
Bone healing by endogenous stem cell mobilization.
BONE.
51:635.
2012
|
|
| 2012
|
DiVerential eVects of low-dose decitabine on immune eVector and suppressor responses in melanoma-bearing mice.
Cancer Immunology, Immunotherapy.
61:1441-1450.
2012
|
|
| 2012
|
Noggin is novel inducer of mesenchymal stem cell adipogenesis: Implications for bone health and obesity.
Journal of Biological Chemistry.
287:12241-12249.
2012
|
|
| 2012
|
Mobilization of bone marrow mesenchymal stem cells in vivo augments bone healing in a mouse model of segmental bone defect.
BONE.
50:1012-1018.
2012
|
|
| 2011
|
Inhibition and promotion of tumor growth with adeno-associated virus carcinoembryonic antigen vaccine and Toll-like receptor agonists.
Cancer Gene Therapy.
18:850-858.
2011
|
|
| 2011
|
Conditionally replicating adenovirus expressing TIMP2 increases survival in a mouse model of disseminated ovarian cancer.
PLoS ONE.
6.
2011
|
|
| 2011
|
LL-37 as a therapeutic target for late stage prostate cancer.
Prostate.
71:659-670.
2011
|
|
| 2011
|
Conditionally replicating adenovirus expressing TIMP2 for ovarian cancer therapy.
Clinical Cancer Research.
17:538-549.
2011
|
|
| 2011
|
Anti-amyloid-β single-chain antibody brain delivery via aav reduces amyloid load but may increase cerebral hemorrhages in an alzheimer's disease mouse model.
Journal of Alzheimer's Disease.
27:23-28.
2011
|
|
| 2010
|
Bacteriophage hyaluronidase effectively inhibits growth, migration and invasion by disrupting hyaluronan-mediated Erk1/2 activation and RhoA expression in human breast carcinoma cells.
Cancer Letters.
298:238-249.
2010
|
|
| 2010
|
Regulation of the activity of an adeno-associated virus vector cancer vaccine administered with synthetic Toll-like receptor agonists.
Vaccine.
28:7837-7843.
2010
|
|
| 2010
|
Merkel cell carcinoma: Correlation of KIT expression with survival and evaluation of KIT gene mutational status.
Human Pathology.
41:1405-1412.
2010
|
|
| 2010
|
Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in diseases of the skeleton.
Journal of Cellular Biochemistry.
111:249-257.
2010
|
|
| 2010
|
Mesenchymal stem cells expressing osteogenic and angiogenic factors synergistically enhance bone formation in a mouse model of segmental bone defect.
Molecular Therapy.
18:1026-1034.
2010
|
|
| 2010
|
Therapeutic potential of genetically modified adult stem cells for osteopenia.
Gene Therapy.
17:105-116.
2010
|
|
| 2009
|
Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in prostate cancer bone metastasis.
Clinical Cancer Research.
15:7175-7185.
2009
|
|
| 2009
|
Free fatty acids enhance breast cancer cell migration through plasminogen activator inhibitor-1 and SMAD4.
Laboratory Investigation.
89:1221-1228.
2009
|
|
| 2009
|
High Cks1 expression in transgenic and carcinogeninitiated mammary tumors is not always accompanied by reduction in p27Kip1.
International Journal of Oncology.
34:1425-1431.
2009
|
|
| 2009
|
Tumoristatic effects of endostatin in prostate cancer is dependent on androgen receptor status.
Prostate.
69:1055-1066.
2009
|
|
| 2009
|
Detection of Merkel cell polyomavirus in formalin-fixed, paraffin-embedded tissue of Merkel cell carcinoma and its correlation with prognosis..
Journal of Clinical Oncology.
27:6027.
2009
|
|
| 2009
|
Pulmonary Angiogenesis in a Rat Model of Hepatopulmonary Syndrome.
Gastroenterology.
136:1070-1080.
2009
|
|
| 2008
|
Genetic modification of adeno-associated viral vector type 2 capsid enhances gene transfer efficiency in polarized human airway epithelial cells.
Human Gene Therapy.
19:1407-1414.
2008
|
|
| 2008
|
Therapeutic potential of mesenchymal stem cells producing interferon-α in a mouse melanoma lung metastasis model.
STEM CELLS.
26:2332-2338.
2008
|
|
| 2008
|
Silencing of transforming growth factor-β1 in situ by RNA interference for breast cancer: Implications for proliferation and migration in vitro and metastasis in vivo.
Clinical Cancer Research.
14:4961.
2008
|
|
| 2008
|
Telomere maintenance in laser capture microdissection - Purified Barrett's adenocarcinoma cells and effect of telomerase inhibition in vivo.
Clinical Cancer Research.
14:4971.
2008
|
|
| 2008
|
Cancer gene therapy using mesenchymal stem cells expressing interferon-β in a mouse prostate cancer lung metastasis model.
Gene Therapy.
15:1446-1453.
2008
|
|
| 2008
|
Clinical significance of a novel single nucleotide polymorphism in the 5′ untranslated region of the Rabphillin-3A-Like gene in colorectal adenocarcinoma.
Frontiers in Bioscience.
13:1050-1061.
2008
|
|
| 2008
|
Therapeutic potential of genetically modified mesenchymal stem cells.
Gene Therapy.
15:711-715.
2008
|
|
| 2008
|
Systemic osteoprotegerin gene therapy restores tumor-induced bone loss in a therapeutic model of beast cancer bone metastasis.
Molecular Therapy.
16:871-878.
2008
|
|
| 2007
|
Bone homing of mesenchymal stem cells by ectopic α4 integrin expression.
Federation proceedings.
21:3917-3927.
2007
|
|
| 2007
|
Effects of sustained antiangiogenic therapy in multistage prostate cancer in TRAMP ,model.
Cancer Research.
67:5789-5797.
2007
|
|
| 2007
|
Targeting EGFR with metabolically biotinylated fiber-mosaic adenovirus.
Gene Therapy.
14:627-637.
2007
|
|
| 2007
|
Notch1 augments intracellular trafficking of adeno-associated virus type 2.
Journal of Virology.
81:2069-2073.
2007
|
|
| 2007
|
Intraperitoneal gene therapy by rAAV provides long-term survival against epithelial ovarian cancer independently of survivin pathway.
Gene Therapy.
14:138-146.
2007
|
|
| 2006
|
Airway epithelium directed gene therapy for cystic fibrosis.
Medicinal Chemistry.
2:499-503.
2006
|
|
| 2006
|
Anti-Aβ single-chain antibody delivery via adeno-associated virus for treatment of Alzheimer's disease.
Neurobiology of Disease.
23:502-511.
2006
|
|
| 2006
|
Activators of viral gene expression in polarized epithelial monolayers identified by rapid-throughput drug screening.
Gene Therapy.
13:781-788.
2006
|
|
| 2006
|
Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands.
Gene Therapy.
13:29-39.
2006
|
|
| 2005
|
Determination of osteoprogenitor-specific promoter activity in mouse mesenchymal stem cells by recombinant adeno-associated virus transduction.
BBA - Gene Structure and Expression.
1731:95-103.
2005
|
|
| 2005
|
Protein transduction of dendritic cells for NY-ESO-1-based immunotherapy of myeloma.
Cancer Research.
65:10041-10049.
2005
|
|
| 2005
|
Genomic stability of self-complementary adeno-associated virus 2 during early stages of transduction in mouse muscle in vivo.
Human Gene Therapy.
16:1047-1057.
2005
|
|
| 2005
|
Recombinant adeno-associated virus 2-mediated antiangiogenic prevention in a mouse model of intraperitoneal ovarian cancer.
Clinical Cancer Research.
11:1342-1347.
2005
|
|
| 2005
|
Antiangiogenic cancer gene therapy by adeno-associated virus 2-mediated stable expression of the soluble FMS-like tyrosine kinase-1 receptor.
Cancer Gene Therapy.
12:26-34.
2005
|
|
| 2004
|
Augmentation of antitumor activity of a recombinant adeno-associated virus carcinoembryonic antigen vaccine with plasmid adjuvant.
Human Gene Therapy.
15:856-864.
2004
|
|
| 2004
|
Detection of disseminated breast cancer growth and treatment response using non-invasive bioluminescence imaging..
Journal of Clinical Oncology.
22:742.
2004
|
|
| 2004
|
Adeno-Associated Virus 2-Mediated Antiangiogenic Cancer Gene Therapy: Long-Term Efficacy of a Vector Encoding Angiostatin and Endostatin over Vectors Encoding a Single Factor.
Cancer Research.
64:1781-1787.
2004
|
|
| 2004
|
Anti-angiogenic gene therapy for cancer (review)..
International Journal of Oncology.
25:335-343.
2004
|
|
| 2004
|
Delivery of DNA to tumor cells in vivo using adeno-associated virus..
Methods in Molecular Biology.
246:237-243.
2004
|
|
| 2004
|
Gene therapy for osteoinduction.
Current Gene Therapy.
4:287-296.
2004
|
|
| 2004
|
Osteogenic differentiation of recombinant adeno-associated virus 2-transduced murine mesenchymal stem cells and development of an immunocompetent mouse model for ex vivo osteoporosis gene therapy.
Human Gene Therapy.
15:1197-1206.
2004
|
|
| 2004
|
Parvovirus vectors for cancer gene therapy.
Expert Opinion on Biological Therapy.
4:53-64.
2004
|
|
| 2002
|
Conjugate-based targeting of recombinant adeno-associated virus type 2 vectors by using avidin-linked ligands.
Journal of Virology.
76:12900-12907.
2002
|
|
| 2002
|
Adenoassociated virus vectors for genetic immunization.
Immunologic Research.
26:247-253.
2002
|
|
| 2001
|
Adeno-associated virus type 2-mediated transduction of human monocyte-derived dendritic cells: Implications for ex vivo immunotherapy.
Journal of Virology.
75:9493-9501.
2001
|
|
| 2001
|
Adeno-associated virus for cancer gene therapy.
Cancer Research.
61:6313-6321.
2001
|
|
| 1999
|
Adeno-associated virus 2-mediated transduction and erythroid lineage- restricted expression from parvovirus B19p6 promoter in primary human hematopoietic progenitor cells.
Journal of Hematotherapy.
8:585-592.
1999
|
|
| 1998
|
Adeno-associated virus type 2-mediated gene transfer: Role of epidermal growth factor receptor protein tyrosine kinase in transgene expression.
Journal of Virology.
72:9835-9843.
1998
|
|
| 1998
|
Characterization of wild-type adeno-associated virus type 2-like particles generated during recombinant viral vector production and strategies for their elimination.
Journal of Virology.
72:5472-5480.
1998
|
|
| 1998
|
Recombinant human parvovirus B19 vectors: Erythroid cell-specific delivery and expression of transduced genes.
Journal of Virology.
72:5224-5230.
1998
|
|
| 1998
|
Adeno-associated virus type 2-mediated gene transfer: Correlation of tyrosine phosphorylation of the cellular single-stranded D sequence-binding protein transgene expression in human cells in vitro and murine tissues in vivo.
Journal of Virology.
72:1593-1599.
1998
|
|
| 1997
|
Adeno-associated virus type 2-mediated transduction in primary human bone marrow-derived CD34+ hematopoietic progenitor cells: Donor variation and correlation of transgene expression with cellular differentiation.
Journal of Virology.
71:8262-8267.
1997
|
|
| 1997
|
Evaluation of recombinant adeno-associated virus as a gene transfer vector for the retina.
Current Eye Research.
16:949-956.
1997
|
|
| 1997
|
Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression.
Proceedings of the National Academy of Sciences.
94:10879-10884.
1997
|
|
| 1997
|
Encapsidation of adeno-associated virus type 2 rep proteins in wild- type and recombinant progeny virions: Rep-mediated growth inhibition of primary human cells.
Journal of Virology.
71:7361-7371.
1997
|
|
| 1997
|
Adeno-associated virus 2-mediated gene transfer in vivo: Organ-tropism and expression of transduced sequences in mice.
Gene.
190:203-210.
1997
|
|
| 1997
|
Adeno-associated virus type 2 DNA replication in vivo: Mutation analyses of the D sequence in viral inverted terminal repeats.
Journal of Virology.
71:3077-3082.
1997
|
|
| 1997
|
Adeno-associated virus type 2-mediated transduction of murine hematopoietic cells with long-term repopulating ability and sustained expression of a human globin gene in vivo.
Journal of Virology.
71:3098-3104.
1997
|
|
| 1997
|
Lack of site-specific integration of the recombinant adeno-associated virus 2 genomes in human cells.
Human Gene Therapy.
8:275-284.
1997
|
|
| 1996
|
Rescue and replication of adeno-associated virus type 2 as well as vector DNA sequences from recombinant plasmids containing deletions in the viral inverted terminal repeats: Selective encapsidation of viral genomes in progeny virions.
Journal of Virology.
70:1668-1677.
1996
|
|
| 1996
|
Adeno-associated virus 2-mediated transduction and erythroid lineage-specific expression in human hematopoietic progenitor cells.
Current Topics in Microbiology and Immunology.
218:93-117.
1996
|
|
| 1996
|
Differential expression in human cells from the p6 promoter of human parvovirus B19 following plasmid transfection and recombinant adeno-associated virus 2 (AAV) infection: Human megakaryocytic leukaemia cells are non-permissive for AAV infection.
Journal of General Virology.
77:1111-1122.
1996
|
|
| 1995
|
Rescue and replication signals of the adeno-associated virus 2 genome.
Journal of Molecular Biology.
250:573-580.
1995
|
|
| 1995
|
Mouse silver. Mutation is caused by a single base insertion in the putative cytoplasmic domain of Pmel 17.
Nucleic Acids Research.
23:154-158.
1995
|
|
| 1995
|
Cord Blood Transplantation and the Potential for Gene Therapy: Gene Transduction Using a Recombinant Adeno‐Associated Viral Vector.
Annals of the New York Academy of Sciences.
770:105-115.
1995
|
|
| 1995
|
Transcriptional transactivation of parvovirus B19 promoters in nonpermissive human cells by adenovirus type 2.
Journal of Virology.
69:8096-8101.
1995
|
|
| 1994
|
Suppression of human α-globin gene expression mediated by the recombinant adeno-associated virus 2-based antisense vectors.
Journal of Experimental Medicine.
179:733-738.
1994
|
|
| 1994
|
Structural organization of the human tyrosinase gene and sequence analysis and characterization of its promoter region.
Journal of Investigative Dermatology.
102:744-748.
1994
|
|
| 1992
|
A cis‐Acting Element Involved in Mouse Tyrosinase Gene Expression and Partial Purification of its Binding Protein.
Pigment Cell Research.
5:155-161.
1992
|
|
| 1992
|
Amelioration of clinical severity through raised fetal hemoglobin in sickle cell anaemia.
Indian Journal of Pediatrics.
59:85-90.
1992
|
|
| 1992
|
Enzymes of the Pentose Phosphate Pathway in Glutathione-Regulated Membrane Protection in β-Thalassaemia.
Clinical Chemistry and Laboratory Medicine.
30:481-484.
1992
|
|
| 1992
|
Enzymes of the pentose phosphate pathway in glutathione-regulated membrane protection in β-thalassaemia.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.
30:481-484.
1992
|
|
| 1990
|
Elevated G gamma:A gamma globin chain ratio in homozygous beta thalassemia..
Clinical Biochemistry.
23:529-531.
1990
|
|
| 1990
|
Elevated Gγ:Aγ globin chain ratio in homozygous beta thalassemia.
Clinical Biochemistry.
23:529-531.
1990
|
|
| 1989
|
Influence of gamma chains in in vitro globin synthesis in β° and β+ homozygous thalassaemia.
Medical Science Research.
17:409-410.
1989
|
|
